TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.

Andrew J Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.